They’re really going for it: emporia launches the first 5G smartphone with a screen warranty
15.7.2026 08:30:00 CEST | news aktuell GmbH | Press Release
Better safe than sorry: the emporiaSMART.8 with Smartcover and rubber protectors

Linz –
- Picture is available at AP -
A moment’s inattention, and the mobile phone falls to the floor. According to the German digital association bitkom, a broken screen is the most common type of damage to smartphones, accounting for 77 per cent of cases, followed by a damaged casing at 41 per cent.
In mid-July, the European smartphone company emporia is launching the emporiaSMART.8 – the world’s first 5G smartphone to come with screen and casing protection included as standard.
1) The patented emporia Smartcover provides all-round protection for the smartphone and allows key functions to be operated even when the cover is closed.
2) The phone is fitted with rubber protectors at the corners. This rubberized edge protection safeguards the phone even when you wish to use it without the Smartcover.
3) emporia display warranty: Within the first twelve months of purchase, emporia will replace a broken display free of charge. In this case, ‘free of charge’ means that emporia will cover the full cost of replacing the high-quality OLED screen, as well as working hours and transport costs.
Info Centre: All notifications in one place
The 6.36-inch mobile comes with a high-performance OLED screen and the latest Android 16 version. Bluetooth 5.4 ensures the best possible connection to headphones, speakers or the hands-free kit in the car. In addition, the ASHA protocol enables audio content to be streamed directly from the smartphone to a hearing aid in high quality.
The SMART.8 comes as standard with the clear, easy-to-use emporia interface, the Info Centre where all notifications are consolidated in one place, the ‘emporiaCOACH’ smartphone training program, and the patented No-Panic Button, which quickly calls for help in an emergency.
The new 5G mobile phone also features wireless charging – older people appreciate the ability to charge their smartphone in the car in this simple way. And for those who are reluctant to let their photos, videos and files disappear into an American cloud, there’s also the option to store their data securely on a 512-gigabyte SD card.
The emporiaSMART.8 is available online (including at emporiamobile.com and on Amazon). Recommended retail price (RRP): 499 euros.
Contacts
emporia Telecom
Walter Deil, Unternehmenssprecher/Company Spokesman
Telefon: +43 670 7010 322
E-Mail: Walter.Deil@emporiamobile.com
Website: https://www.emporiamobile.com
Images

Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
“Wheel of Watt”: PLAN-B NET ZERO launches prize draw with instant prizes and a €1,000,000 top prize15.7.2026 12:45:34 CEST | Press Release
Three prize tiers, one big goal: from 15 July 2026, the digital energy supplier specialising in renewable energy is giving away instant prizes, monthly non-cash prizes and a top prize of €1,000,000. The full terms and conditions of participation set out all the details.
FEV collaborates with Microsoft on efficient AI model approach for in‑car applications built on NVIDIA9.7.2026 11:05:00 CEST | Press Release
Aachen – FEV is collaborating with Microsoft to integrate powerful, in-vehicle Generative AI capabilities . The cooperation aims to enable multimodal voice, text, and gesture interactions directly in the vehicle – independent of a permanent Internet connection.
Acrobat Studio och Acrobat AI Assistant: nya generationens AI-drivna produktivitet – nu på svenska8.7.2026 15:02:57 CEST | Press Release
SAN JOSE, Kalifornien – 08 juli 2026 – Adobe utökar tillgängligheten till Acrobat Studio och Acrobat AI Assistant i Sverige. De AI-drivna funktionerna för produktivitet och kreativitet erbjuds nu även på svenska, så att användarna kan använda dem på sitt lokala språk. Acrobat Studio kombinerar Adobe Acrobat Pro, Adobe Express Premium och intelligenta AI-assistenter. Acrobat AI Wizard erbjuds dessutom som ett separat tillägg för alla Adobe Acrobat-produkter (Acrobat Reader, Acrobat Standard och Acrobat Pro) – ett flexibelt alternativ för alla som vill använda AI-drivna funktioner endast när de arbetar med dokument. Båda dessa erbjudanden gör det möjligt för användare att snabbare komma åt information i PDF-filer och Office-dokument, skapa innehåll och effektivisera arbetsflöden. Acrobat Studio och Acrobat AI Assistant är en viktig milstolpe i vidareutvecklingen av PDF, som har etablerat sig över hela världen som standardformatet för viktiga dokument sedan Adobes lansering år 1993. Acrob
Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy8.7.2026 10:22:07 CEST | Press Release
Aachen, 08 July 2026 – Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD). Tegacorat, a non-steroidal Selective Glucocorticoid Receptor Agonist and Modulator (SEGRAM), is an orally available investigational compound being developed to provide an alternative to glucocorticoid-based treatments such as prednisone, the current standard of care in DMD. Conventional glucocorticoids bind to the glucocorticoid receptor and influence gene expression. Among other mechanisms, this triggers two patterns of activity: transrepression, mainly linked to anti-inflammatory effects, and transactivation, predominantly associated with metabolic and growth-related side effects. In contrast, SEGRAMs are designed to influence receptor activity in a way that emphasises anti-inflammatory pathways. While this has not yet be
Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist29.6.2026 11:58:39 CEST | Press Release
The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. A Phase II trial will commence later this year.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom